Health Care/Hospital
PeriGen Applauded by Frost & Sullivan for Its Innovative Perinatal Software Solutions for Fetal Monitoring and Clinical Decision Support
PeriGen's perinatal information systems provide the most accurate and holistic approach for monitoring infant and maternal health, enhancing clinical efficiency, allowing timely intervention, and promoting standardized care. SAN ANTONIO, July 19, 2022 /PRNewswire/ -- Recently, Frost & Sullivan r...
Seegene launches world's first In-life PCR campaign in Vietnam
* Test center LabHouse and ride-hailing service Grab to start PCR testing for Grab drivers in August * Seegene to provide Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay to simultaneously detect COVID-19, flu, cold * Testing to begin with drivers in Ho Chi Minh, Hanoi and will later be expanded to ...
Oncoshot Enters Collaboration Agreement With Omico (Australian Genomic Cancer Medicine Centre)
SINGAPORE, July 19, 2022 /PRNewswire/ – Oncoshot has just entered into a collaboration agreement with Omico, the Australian Genomic Cancer Medicine Centre. The respective parties were represented at the event yesterday by Dr Huren Sivaraj, CEO and co-founder of Oncoshot, and Prof David Thomas, ...
WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore
* This investment will establish a cutting-edge, fully integrated CRDMO center inSingapore, including a research and development service center and large-scale drug substance and drug product manufacturing facilities for biologics * The investment strengthens WuXi Biologics' global research, ...
Antengene Announces Research Collaboration with Celularity to Evaluate the Potential Therapeutic Synergy of Combining Antengene's Best-in-Class Bispecific Antibody with Celularity's Natural Killer Cell Platform
- This research collaboration marks Antengene's entry into the field of cellular medicines. SHANGHAI and HONG KONGJuly 19, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discover...
WuXi AppTec Plans to Build a New Site in Singapore, Better Serving Global Partners and Advancing Healthcare Innovation
SINGAPORE, July 19, 2022 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufacturing services that enable the global pharmaceutical and healthcare industry, today announced a plan to build a new R&D and manufacturing site inSingapore. The company intends to invest up to S$2 bi...
DarwinHealth Publishes Results of Novel, Viral Checkpoint-based Technology for Predicting Drugs that Inhibit SARS-CoV-2 Replication: Global Collaboration Highlights Generalizability of Reported ViroTreat Model for Host Cell-Directed Antiviral Drug Discovery, the Role of Master Regulator Proteins, and Application to other Viral Pathogens and Pandemic Response
NEW YORK, July 19, 2022 /PRNewswire/ -- DarwinHealth, Inc., a New York-based biotechnology and cancer drug discovery company announces theJuly 19, 2022 online publication in Communications Biology (a Nature Portfolio peer-reviewed journal) of a foundational paper focused on new approaches to anti...
Guo Guangchang Visits Fosun's Member Companies in Hamburg, Germany and Meets Carola Veit, President of Hamburg Parliament
HONG KONG, July 19, 2022 /PRNewswire/ -- On 18 July 2022, Mr. Guo Guangchang, Chairman of Fosun International, and his delegation visited Yuyuan inHamburg, and German lifestyle fashion brandTom Tailor. He also met and had lunch with Ms. Carola Veit, President of the Hamburg Parliament. Mr. Marco W...
World Brain Day 2022 Will Feature Leading Experts to Promote Brain Health
LONDON, July 20, 2022 /PRNewswire/ -- July 22 is devoted to Brain Health for All for World Brain Day (WBD). This year, in a free webinar, the World Federation of Neurology (WFN) is featuring leading experts from regional and global organizations who are prioritizing brain health, including the Wor...
Brii Bio Announces Strategic Partnership with China Resources Pharmaceutical Commercial Group to Advance the Commercialization of Long-acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China The amubarvimab/romlusevimab combination is the first locally-discovered and approved SARS-CoV-2 target-specific treatment inChina, evaluated through a rand...
llumina Among First in the World to Receive Approval of Science-Based Net-Zero Target
The Science Based Targets initiative has validated Illumina's targets to reach Net-Zero greenhouse gas emissions by 2050 SINGAPORE, July 19, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today it is among the first g...
Significant Glycemic Control and Weight Loss: Innovent Announces Phase 2 Study of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Met Primary Endpoint
SAN FRANCISCO and SUZHOU, China, July 19, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and o...
USAID Announces $200 Million Commitment to Tackle Child Wasting, the Largest Single Investment in Malnutrition Treatment in History
With co-investment from philanthropist Sir Chris Hohn, the CRI Foundation, the Eleanor Crook Foundation, and The ELMA Relief Foundation, this monumental commitment will drive more than a 50% increase in the number of severely malnourished children who receive treatment with Ready-to-use Therapeut...
SHL Medical announces plans for a new manufacturing site in the US
NORTH CHARLESTON, S.C., July 18, 2022 /PRNewswire/ -- SHL Medical (hereinafter referred to as "SHL") has revealed plans for a new manufacturing site in the US, in response to the growing market demand for its autoinjector product portfolio. The decision stems from SHL's strategic assessments in e...
Omega Healthcare Named "Star Performer" in Revenue Cycle Management (RCM) Operations PEAK Matrix® Assessment 2022
Marks the fifth year that Omega has been ranked as a market leader by Everest Group BOCA RATON, Fla., July 18, 2022 /PRNewswire/ -- Omega Healthcare, a leading healthcare management solutions partner supporting the broad healthcare ecosystem, was recently named "Star Performer" in Revenue Cycle ...
BRONCUS COMPLETED SURGERIES ON THE FIRST GROUP OF PATIENTS USING ITS InterVapor®, THE THERMAL VAPOR TREATMENT SYSTEM, AFTER APPROVED FOR MARKETING IN CHINA
HANGZHOU, China, July 18, 2022 /PRNewswire/ -- Broncus Medical (02216.HK) has completed surgeries on the first group of patients using its InterVapor® (including InterVapor Generator and InterVapor Catheter, the "InterVapor®"), after it was approved for marketing inChina. This marked the official ...
AXA introduces the "BeOnTrack Programme", an all-in-one solution for participants to restore and build a healthy lifestyle
Expert trio to formulate health improvement plans through professional consultations, self-monitoring and laboratory tests HONG KONG, July 18, 2022 /PRNewswire/ -- AXA Hong Kong and Macau (AXA) today announced the launch of its "BeOnTrack Programme" ("BeOnTrack" or the "Programme"). At onlyHKD10...
FWD Group Jumps to Number 6 in 2022 MDRT Rankings
HONG KONG, July 18, 2022 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "the Company") rose to number six in the2022 Million Dollar Round Table ("MDRT") Top 10 Multinational Companies rankings. The Company climbed four positions from last year, maintaining positive growth despite the ...
Everest Medicines Announces European Commission Grants Approval of Kinpeygo® for Adults with Primary IgA Nephropathy to our Partner Calliditas Therapeutics
Kinpeygo® (developed under the name NEFECON) is the first and only EMA- approved treatment for IgAN Everest Medicines has exclusive rights to develop and commercialize NEFECON in Greater China, Singapore and South Korea SHANGHAI, July 18, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Ev...
Amaris B. Clinic Is Seeing More Patients for Liposuction Due To Inefficacy of Non-surgical Fat Reduction Treatments
Dr Ivan Puah, Medical Director at Amaris B. Clinic, has been performing modern liposuction and corrective surgeries for patients who have experienced less than satisfactory results from non-surgical treatments and those who suffer from PAH, a rare side effect of cryolipolysis. SINGAPORE, Ju...
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24